Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial

1. Motzer, R.J.
2. Russo, P.
3. Grünwald, V.
4. Tomita, Y.
5. Zurawski, B.
6. Parikh, O.
7. Buti, S.
8. Barthélémy, P.
9. Goh, J.C.
10. Ye, D.
11. Lingua, A.
12. Lattouf, J.-B.
13. Albigès, L.
14. George, S.
15. Shuch, B.
16. Sosman, J.
17. Staehler, M.
18. Vázquez Estévez, S.
19. Simsek, B.
20. Spiridigliozzi, J.
21. Chudnovsky, A.
22. Bex, A.